Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
How M-Power Is Building Trust to Raise Awareness of Multiple Myeloma in the Black Community
International Myeloma Foundation Chief Medical Office Joseph Mikhael, MD, shares how the M-Power initiative is addressing disparities through community engagement, education, and improved clinical trial access.